Outpatient-Polyclinic Register of the Multidisciplinary Medical Center (TERRA): general characteristics and first results

Aim. To describe the experience of creating the Outpatient-Polyclinic Register of the Multi-specialty Medical Center (TERRA) and the first results of the study.

Material and methods. The TERRA registry included 32264 patients (age 44,0±15,3 years; 32,2% men) who applied to the multidisciplinary medical center from January 1, 2018 to December 31, 2021. Information from electronic outpatient records was evaluated. The data of patients with/without cardiovascular diseases (CVDs) in those who applied to general practitioners, cardiologists and other specialists, those with and without coronavirus disease 2019 (COVID-19) were compared.

Results. There were 26,8% of patients with CVDs, while with ≥2 CVD — 8,1%, with CVD and/or chronic non-cardiac disease — 54,1%, their combination — 26%. Among those who consulted cardiologists, general practitioners and doctors of other specialties, hypertension was most often recorded — 64,8; 34,9 and 18,6%, coronary artery disease — 15,1, 6,2 and 3,2%, while from chronic non-cardiac diseases — diseases of the digestive system (64,4; 58,0 and 33,7%), kidneys (29,8; 24,9 and 13,2%), respiratory organs (28,4; 23,8 and 12,6%). The proportion of COVID-19 survivors was 8.2%, in patients with and without CVD — 14,8 and 5,1%, respectively (p<0,001). The proportion of CVD cases among survivors and non-survivors of COVID-19 was 58,0% and 25,2%, respectively (p<0,001). In addition, 88% of patients with CVDs consulted a cardiologist or general practitioner, of which 42% were observed by them together.

Conclusion. The majority of patients at the multidisciplinary medical center had CVDs and chronic non-cardiac diseases, and more than a quarter had a combination of both. Patients with CVDs were more likely to have chronic non-cardiac diseases (2,2 times) and a history of COVID-19 (2,9 times). Among patients with a history of COVID-19, there was a higher proportion of cases of CVDs (by 2,3 times) and chronic non-cardiac pathology (by 1,8 times). Almost half of patients with CVD were observed jointly by a cardiologist and a general practitioner.

1. Ageeva LI, Aleksandrova GA, Golubev NA, et al. Healthcare in Russia 2021. Rosstat. M. 2021. p.171. (In Russ.)

2. Boytsov SA, Martsevich SY, Kutishenko NP, et al. Registers in cardiology: their principles, rules, and real-word potential. Cardiovascular Therapy and Prevention. 2013;12(1):4-9. (In Russ.) doi:10.15829/1728-8800-2013-1-4-9.

3. Oschepkova EV, Aksenova AV, Orlovsky AА, et al. Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry). Terapevticheskii arkhiv. 2022;94(7):810-5. (In Russ.) doi:10.26442/00403660.2022.07.201744.

4. Sagaydak OV, Oschepkova EV, Chazova IE. Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016-2019. Terapevticheskii arkhiv. 2022;94(7):797-802. (In Russ.) doi:10.26442/00403660.2022.07.201732.

5. Tolpygina SN, Zagrebelny AV, Chernysheva MI, et al. Long-term survival of patients with cerebrovascular accident in different age groups in the REGION-M registry. Russian Journal of Cardiology. 2023;28(2):5250. (In Russ.) doi:10.15829/1560-4071-2023-5250.

6. Drapkina OM, Karpov OE, Loukianov MM, et al. Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID19) and community-acquired pneumonia (TARGET-VIP). The Russian Journal of Preventive Medicine. 2020;23(8):6-13. (In Russ.) doi:10.17116/profmed2020230816.

7. Smirnov AA, Loukianov MM, Martsevich SYu, et al. Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19. Rational Pharmacotherapy in Cardiology. 2022;18(5):502-9. (In Russ.) doi:10.20996/1819-6446-2022-09-06.

8. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register "Dynamics analysis of comorbidities in SARS-CoV-2 survivors" (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):4165. (In Russ.) doi:10.15829/1560-4071-2020-4165.

9. van Oostrom SH, Gijsen R, Stirbu I, et al. Time trends in preva­lence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS One. 2016;11(8):e0160264. doi:10.1371/journal.pone.0160264.

10. Williams JS, Egede LE. The Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability. Am J Med Sci. 2016;352(1):45-52. doi:10.1016/j.amjms.2016.03.004.

11. Di Angelantonio E, Kaptoge S, Wormser D, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52-60. doi:10.1001/jama.2015.7008.

12. Rodrigues LP, de Oliveira Rezende AT, Delpino FM, et al. Association between multimorbidity and hospitalization in older adults: systematic review and meta-analysis. Age Ageing. 2022;51(7):afac155. doi:10.1093/ageing/afac155.

13. Cassell A, Edwards D, Harshfield A, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2018;68:e245-51. doi:10.3399/bjgp18X695465.

14. Coste J, Valderas JM, Carcaillon-Bentata L. Estimating and characterizing the burden of multimorbidity in the com­munity: A comprehensive multistep analysis of two large nationwide representative surveys in France. PLoS Med. 2021;18(4):e1003584. doi:10.1371/journal.pmed.1003584.

15. Bakken IJ, Ariansen AMS, Knudsen GP, et al. The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries. Scand J Public Health. 2020;48(1):49-55. doi:10.1177/1403494819859737.

16. Ward BW, Myrick KL, Cherry DK. Physician Specialty and Office Visits Made by Adults With Diagnosed Multiple Chronic Conditions: United States, 2014-2015. Public Health Rep. 2020;135(3):372-82. doi:10.1177/0033354920913005.

17. Hinton W, McGovern A, Coyle R, et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018;8:e020282. doi:10.1136/bmjopen-2017-020282.

18. Harrison C, Henderson J, Miller G, et al. The prevalence of dia­gnosed chronic conditions and multimorbidity in Austra­lia: A method for estimating population prevalence from gene­ral practice patient encounter data. PLoS One. 2017;12(3): e0172935. doi:10.1371/journal.pone.0172935.

19. Zhou Z, Shi M, Liu M, et al. Multimorbidity in Hospitalized Patients Admitted to General Practice Departments and Its Implications for the General Practice Healthcare System: A Four-Year Longitudinal Study in China. Front Public Health. 2021;9:760792. doi:10.3389/fpubh.2021.760792.

20. Lochner KA, Cox CS. Prevalence of multiple chronic conditions among medicare beneficiaries, United States, 2010. Prev Chronic Dis. 2013;10:E61. doi:10.5888/pcd10.120137.

21. Miller PE, Thomas A, Breen TJ, et al. Prevalence of Noncardiac Multimorbidity in Patients Admitted to Two Cardiac Intensive Care Units and Their Association with Mortality. Am J Med. 2021;134(5):653-61.e5. doi:10.1016/j.amjmed.2020.09.035.

22. Banerjee A, Chen S, Pasea L, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021;28(14):1599-609. doi:10.1093/eurjpc/zwaa155.

23. Alexander GC, Tajanlangit M, Heyward J, et al. Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US. JAMA Netw Open. 2020;3:e2021476. doi:10.1001/jamanetworkopen.2020.21476.

24. Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021;9:413-5. doi:10.1016/S2213-8587(21)00116-9.

25. Ferat LR, Forrest R, Sehmi K, et al. Preventing the Next Pandemic: The Case for Investing in Circulatory Health — A Global Coalition for Circulatory Health Position Paper. Glob Heart. 2021;16(1):66. doi:10.5334/gh.1077.

26. Drapkina OM, Karpov OE, Loukianov MM, et al. Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes. Cardiovascular Therapy and Prevention. 2020;19(6):2727. (In Russ.) doi:10.15829/1728-8800-2020-2727.

27. Salah HM, Fudim M, O’Neil ST, et al. Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study. Nat Commun. 2022;13(1):4117. doi:10.1038/s41467-022-31834-y.

28. Yu C, Lei Q, Li W, et al. Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: A retrospective study in wuhan, China. Am J Prev Med. 2020;59(2):168-75. doi:10.1016/j.amepre.2020.05.002.

29. Ng WH, Tipih T, Makoah NA, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio. 2021;12(1):e03647-20. doi:10.1128/mBio.03647-20.

30. Horton R. Offline: COVID-19 is not a pandemic. Lancet. 2020; 396(10255):874. doi:10.1016/S0140-6736(20)32000-6.